title: [Therapeutic consequences of hemorheologic research].
abstract: One of the possibilities to ameliorate blood perfusion is the modification of the rheological properties of blood. Hemodilution, enzymatic defibrinogenation and oral drugs are available at present to achieve this aim. Hemodilution is clinically successful with certain indications. The efficacy of enzymatic defibrinogenation cannot be judged finally. Within the group of rheologically active drugs a variety of substances are of proven effectiveness. Yet it is open whether this is brought about exclusively by hemorheological mechanisms.
authors.affiliation: Medizinische Hochschule Hannover, Abt. Physikalische Medizin und Rehabilitation.
authors.forename: E
authors.initials: E
authors.lastname: Ernst
mesh_terms: D001157:Arterial Occlusive Diseases / Q000628:therapy*; D001809:Blood Viscosity / Q000187:drug effects; D003131:Combined Modality Therapy; D004907:Erythrocyte Deformability / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006438:Hemodilution / Q000379:methods; D006801:Humans; D012212:Rheology
chemical_list: D005343:Fibrinolytic Agents
vernacular_title: Therapeutische Konsequenzen hämorheologischer Forschung.